Akingbolabo Daniel Ogunlakin

Dr. Akingbolabo Daniel Ogunlakin

Bowen University, Iwo, Osun, Nigeria
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
Akingbolabo Daniel OgunlakinAkingbolabo Daniel Ogunlakin
Akingbolabo Daniel Ogunlakin
MSMubo Adeola Sonibare
Mubo Adeola Sonibare
OYOloruntoba Emmanuel Yeye
Oloruntoba Emmanuel Yeye
GGGideon Gyebi
Gideon Gyebi
DADamilare IyinKristi Ayokunle
Damilare IyinKristi Ayokunle
Oluwafemi Adeleke OjoOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo

25 September 2024 in Life
Verified
Journal Article
Open access
PDF file
Oluwafemi Adeleke OjoOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
OAOmolola Ajayi-Odoko
Omolola Ajayi-Odoko
GGGideon Gyebi
Gideon Gyebi
DADamilare IyinKristi Ayokunle
Damilare IyinKristi Ayokunle
Akingbolabo Daniel OgunlakinAkingbolabo Daniel Ogunlakin
Akingbolabo Daniel Ogunlakin
OAOluyomi Stephen Adeyemi
Oluyomi Stephen Adeyemi
Alzheimer’s disease (AD) is an age-associated neurodegenerative condition marked by amyloid plaques, synaptic dysfunction, and neuronal loss. Besides conventional medical care, herbal therapies, both raw and refined, have attracted researchers for their potential therapeutic effects. As a proof-of-concept, our study combined HPLC-DAD analysis of bioactive constituents, network pharmacology, molecular dynamics (MD), molecular docking, post-MD analysis, and experimental verification to investigate the mechanisms of crude drug formulations as a therapeutic strategy for AD. We identified nine bioactive compounds targeting 188 proteins and 1171 AD-associated genes. Using a Venn diagram, we found 47 overlapping targets, forming “herb-compound-target (HCT)” interaction networks and a protein‒protein interaction (PPI) network. Simulations analyzed binding interactions among the three core targets and their compounds. MD assessed the stability of the best-ranked poses and beneficial compounds for each protein. Among the top 22 hub genes, AChE, BChE, and MAO, ranked 10, 14, and 34, respectively, were selected for further analysis. Two tetraherbal formulations, Form A and Form B, showed notable activity against AChE. Form A exhibited significant (p < 0.0001) inhibitory activity (IC50 = 114.842 ± 2.084 µg/mL) compared to Form B (IC50 = 142.829 ± 4.258 µg/mL), though weaker than galantamine (IC50 = 27.950 ± 0.122 µg/mL). Form B had significant inhibitory effects on BChE (IC50 = 655.860 ± 32.812 µg/mL) compared to Form A (IC50 = 679.718 ± 20.656 µg/mL), but lower than galantamine (IC50 = 23.126 ± 0.683 µg/mL). Both forms protected against Fe2+-mediated brain injury by inhibiting MAO. Docking identified quercetin (−10.2 kcal/mol) and myricetin (−10.1 kcal/mol) for AChE; rutin (−10.6 kcal/mol) and quercetin (−9.7 kcal/mol) for BChE; and kaempferol (−9.1 kcal/mol) and quercetin (−8.9 kcal/mol) for MAO. These compounds were thermodynamically stable based on MD analysis. Collectively, the results offer a scientific rationale for the use of these specifically selected medicinal herbs as AD medications.

20 June 2025 in Plants
Verified
Journal Article
Open access
PDF file
OEOchuko Lucky Erukainure
Ochuko Lucky Erukainure
CCChika Ifeanyi Chukwuma
Chika Ifeanyi Chukwuma
JNjennifer nambooze
jennifer nambooze
STSatyajit Tripathy
Satyajit Tripathy
VSVeronica Salau
Veronica Salau
JUJeremiah Unuofin
Jeremiah Unuofin
Diabetes is one of the major non-communicable diseases whose physiological complications are linked with a higher risk of mortality amongst the adult age group of people living globally. This review article documents updated pharmacological evidence and insights into the antidiabetic mechanisms of green, black, white, oolong, and pu-erh teas via reported experimental and clinical models toward encouraging their use as a complementary nutraceutical in managing the biochemical alterations found in the onset and progression of diabetes. Peer-reviewed articles published in “PubMed”, “Google Scholar”, and “ScienceDirect” from 2010 and beyond that reported the antidiabetic, antilipidemic, and digestive enzyme inhibitory effects of the selected tea types were identified. The keywords used for the literature search comprise the common or scientific names of the tea and their corresponding bioactivity. Although teas portrayed different antidiabetic pharmacological properties linked to their bioactive components, including polyphenols, polysaccharides, and amino acids, the type of phytochemical found in each tea type depends on their processing. Green tea’s strong carbohydrate digestive enzyme inhibitory effect was linked with Ellagitannins and catechins, whereas theaflavin, a main ingredient in black tea, increases insulin sensitivity via enhancing GLUT4 translocation. Theabrownin in pu-erh tea improves FBG and lipid metabolism, while chemical components in white tea attenuate prediabetes-mediated reproductive dysfunctions by improving testicular tissue antioxidant capabilities. Based on the body of findings presented in this article, it is evident that integrating tea intake into daily food consumption routines could offer a promising practical solution to support human health and well-being against diabetes disease.

13 September 2024 in Phytomedicine Plus
Verified
Journal Article
Open access
AOAdesoji Alani Olanrewaju
Adesoji Alani Olanrewaju
Akingbolabo Daniel OgunlakinAkingbolabo Daniel Ogunlakin
Akingbolabo Daniel Ogunlakin
UOUchenna Obike
Uchenna Obike
GGGideon Gyebi
Gideon Gyebi
OOOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
MSMubo Adeola Sonibare
Mubo Adeola Sonibare

7 September 2023 in Chemistry Africa
Verified
Journal Article
Closed access
PDF file
Akingbolabo Daniel OgunlakinAkingbolabo Daniel Ogunlakin
Akingbolabo Daniel Ogunlakin
MSMubo Adeola Sonibare
Mubo Adeola Sonibare
OYOloruntoba Emmanuel Yeye
Oloruntoba Emmanuel Yeye
AJAlmas Jabeen
Almas Jabeen
SSSyeda Farah Shah
Syeda Farah Shah
DADamilare IyinKristi Ayokunle
Damilare IyinKristi Ayokunle

13 October 2023 in Molecules
Verified
Journal Article
Open access
PDF file
OAOpeyemi Josephine Akinmurele
Opeyemi Josephine Akinmurele
MSMubo A. Sonibare
Mubo A. Sonibare
AEAnthony A. Elujoba
Anthony A. Elujoba
Akingbolabo Daniel OgunlakinAkingbolabo Daniel Ogunlakin
Akingbolabo Daniel Ogunlakin
OYOloruntoba Emmanuel Yeye
Oloruntoba Emmanuel Yeye
AAAbdullah Rajaa Alanzi
Abdullah Rajaa Alanzi
Background: Alstonia boonei, belonging to the family Apocynaceae, is one of the best-known medicinal plants in Africa and Asia. Stem back preparations are traditionally used as muscle relaxants. This study investigated the antispasmodic properties of Alstonia boonei Stem back and its constituents. Method: The freeze-dried aqueous Stem back extract of A. boonei, as well as dichloromethane (DCM), ethyl acetate, and aqueous fractions, were evaluated for their antispasmodic effect via the ex vivo method. Two compounds were isolated from the DCM fraction using chromatographic techniques, and their antispasmodic activity was evaluated. An in silico study was conducted by evaluating the interaction of isolated compounds with human PPARgamma-LBD and human carbonic anhydrase isozyme. Results: The Stem back crude extract, DCM, ethyl acetate, and aqueous fractions showed antispasmodic activity on high-potassium-induced (K+ 80 mM) contractions on isolated rat ileum with IC50 values of 0.03 ± 0.20, 0.02 ± 0.05, 0.03 ± 0.14, and 0.90 ± 0.06 mg/mL, respectively. The isolated compounds from the DCM fraction were β-amyrin and boonein, with only boonein exhibiting antispasmodic activity on both high-potassium-induced (IC50 = 0.09 ± 0.01 µg/mL) and spontaneous (0.29 ± 0.05 µg/mL) contractions. However, β-amyrin had a stronger interaction with the two proteins during the simulation. Conclusion: The isolated compounds boonein and β-amyrin could serve as starting materials for the development of antispasmodic drugs.